Skip to main content
. 2014 Sep 3;45(5):1847–1856. doi: 10.3892/ijo.2014.2634

Figure 5.

Figure 5

Antitumor activity of γδ T cells and GPC3-specific CTLs in vivo. We subcutaneously inoculated (A) SK-Hep-1/vec or (B) SK-Hep-1/hGPC3 cells into NOD/SCID mice and intravenously injected effector cells. We performed adoptive cell transfer of expanded cells using five mice per group. Data represent the means ± SD. (A) The growth of SK-Hep-1/vec treated with CD8 cells or all cells was significantly inhibited. The growth of SK-Hep-1/vec treated with CD8+ cells was not inhibited. (B) The growth of SK-Hep-1/hGPC3 treated with CD8+ or CD8 cells was significantly inhibited. In addition, treatment with all cells, including both CD8+ and CD8 cells, showed an additive inhibitory effect.